OCRHIPAA Security Rule

HIPAA Technical Safeguards (45 CFR 164.312)

Five standards covering access control, audit controls, integrity, person or entity authentication, and transmission security for ePHI.

Primary source

45 CFR 164.312 — eCFR

https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-C/part-164/subpart-C/section-164.312

Verified May 23, 2026 · This is the authoritative regulator URL. The summary below is a research aid; the linked source controls.

45 CFR 164.312 sets five technical safeguard standards.

Access Control (a)(1): unique user identification (R), emergency access procedure (R), automatic logoff (A), encryption and decryption (A).

Audit Controls (b): hardware, software, and procedural mechanisms that record and examine activity in systems containing ePHI. Required.

Integrity (c)(1): policies to protect ePHI from improper alteration or destruction. Spec: authentication of ePHI (A).

Person or Entity Authentication (d): verify the identity of any person or entity accessing ePHI. Required.

Transmission Security (e)(1): protect against unauthorized access to ePHI during transmission. Specs: integrity controls (A), encryption (A).

The standards are technology-neutral but the encryption addressable specification, in particular, is the implicit baseline for any system carrying ePHI over the internet — TLS 1.2+ in transit, AES-256 at rest. A risk analysis that concludes encryption is not reasonable and appropriate for ePHI traversing the public internet is difficult to defend.

Use this in your workspace

D3rx assembles the documentation linked to this regulation, walks the practical decisions in plain English, and stores the artifacts against the .gov sources cited above. It is an administrative research aid, not a substitute for counsel.

Related regulations

Authored by D3rx

D3rx is a healthcare-billing and compliance research aid maintained by D3rx Inc. Articles are drafted by an LLM (Anthropic Claude) against primary HHS, OCR, CMS, eCFR, NIST, and state-regulator publications, and reviewed for restraint and source fidelity by the D3rx team.

Reviewer status: a named credentialed reviewer (CHC, CHPC, or healthcare attorney) is being engaged. Until that engagement is finalized, this page does not claim credentialed review.

Last reviewed May 23, 2026 · Citation verified May 23, 2026

Research aid, not legal advice. This summary is an administrative research aid prepared by D3rx. It does not certify compliance, provide legal advice, replace counsel, or guarantee an audit outcome. For authoritative regulatory text follow the primary source link at the top of this page. The practice remains responsible for reviewing, adopting, and maintaining its compliance program.